Astatine-211 targets blood-borne cancers in Seattle clinical trials

September 13, 2022, 9:30AMNuclear News
A clinical dose of At-211 is prepared at the University of Washington for use in a Fred Hutchison Cancer Center clinical trial. (Photo: UW/Don Hamlin)

Scientists in the Departments of Radiation Oncology and Medicine at the University of Washington (UW) and Fred Hutchinson Cancer Center (Fred Hutch) are directly targeting cancerous cells traveling through patients’ bloodstreams with diseases such as leukemia and lymphoma using an intravenous injection of the radioactive isotope astatine-211 (At-211). The work, its challenges, and its promise were described in a recent news release from the National Isotope Development Center (NIDC), which is managed by the Department of Energy’s Isotope Program.

To continue reading, log in or create a free account!

Related Articles

On moving fast and breaking things

March 16, 2026, 9:33AMNuclear NewsCraig Piercy

So much of what is happening in federal nuclear policy these days seems driven by a common approach popularized in the technology sector. Silicon Valley calls it “move fast and break...

Webinar highlights Gen IV reactors

March 16, 2026, 7:31AMANS News

The American Nuclear Society recently hosted a new webinar in its ongoing Educator Training series titled “Perspectives on Generation IV Reactors.” It was led by Edward A. Friedman,...

Aalo Atomics discusses the road ahead

March 12, 2026, 1:13PMNuclear News

Yasir Arafat, president and chief technology officer of Aalo Atomics, participated in the first day of sessions at the Nuclear Regulatory Commission’s annual Regulatory Information...

Return of the HB Line at SRS

March 11, 2026, 5:02PMNuclear News

The Department of Energy is bringing the HB Line facility at the Savannah River Site back on line to recycle surplus plutonium and produce uranium-plutonium mixed oxide (MOX) fuel for advanced...

DOE releases 2025 NEUP and NSUF funding

March 6, 2026, 1:06PMNuclear News

On March 3, the Department of Energy announced the release of $52.8 million in funds through the Nuclear Energy University Program (NEUP) and the Nuclear Science User Facilities (NSUF)...